2.3. Pathological Complete Response (pCR) to Neoadjuvant Chemotherapy (NAC) Is Associated with Less Treg Abundance in Triple Negative Breast Cancer (TNBC) but Not in ER-Positive/Her2-Negative Breast Cancer. This evidence concerns the gene ESR1 and breast carcinoma.